Alkermes Earnings
NASDAQ: ALKSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 1:41 PM ET
Next earnings date
Tue, Oct 27, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.08
Alkermes earnings summary
Alkermes is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $-0.08. In its most recent report on Jul 28, 2026 (Q2 2026), ALKS posted EPS of $0.00. Revenue for the quarter was $496.0 million.
Quarterly EPS is down 100.0% from the same quarter a year earlier. Across the last 16 reports, ALKS shares moved an average of 2.9% (in either direction) in the first trading session after results, rising 8 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
ALKS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 28, 2026 | — | $0.00 | — | +0.4% |
| May 5, 2026 | — | $-0.40 | — | +7.1% |
| Feb 25, 2026 | — | $0.29 | — | -4.9% |
| Oct 28, 2025 | — | $0.49 | — | +7.1% |
| Jul 29, 2025 | — | $0.52 | — | +0.6% |
| May 1, 2025 | — | $0.13 | — | -5.2% |
| Feb 12, 2025 | — | $0.88 | — | -1.6% |
| Oct 24, 2024 | — | $0.55 | — | +1.5% |
| Jul 24, 2024 | — | $0.53 | — | -0.6% |
| May 1, 2024 | — | $0.21 | — | 0.0% |
| Feb 21, 2024 | — | $0.69 | — | +2.3% |
| Oct 25, 2023 | — | $0.28 | — | +3.7% |
| Jul 26, 2023 | — | $1.38 | — | -4.0% |
| Apr 26, 2023 | — | $-0.25 | — | +3.2% |
| Feb 16, 2023 | — | $-0.18 | — | -3.2% |
| Nov 2, 2022 | — | $-0.39 | — | -1.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.